AvroBio, Inc
1 known investors
AVROBIO develops investigational gene therapies that use a patient's own stem cells to treat serious lysosomal disorders, aiming to halt or reverse genetic disease with a single dose. Its therapies are built on a proprietary gene therapy platform called plato.
Investors Β· 1
Frequently asked questions
- What does AvroBio, Inc do?
- AVROBIO develops investigational gene therapies that use a patient's own stem cells to treat serious lysosomal disorders, aiming to halt or reverse genetic disease with a single dose. Its therapies are built on a proprietary gene therapy platform called plato.
- Who are AvroBio, Inc's investors?
- AvroBio, Inc's investors include SV Health Investors.